Hypoalbuminemia and hypergammaglobulinemia are associated with an increased infection risk in patients with myeloid malignancies treated with azacitidine. A 3-year monocentric retrospective study. Issue 6 (2nd June 2016) - Stamatoullas, Aspasia; Rezine, Imene; Mareschal, Sylvain; Lise Ménard, Anne; Lanic, Hélène; David, Marion; Daliphard, Sylvie; Penther, Dominique; Lemasle, Emilie; Cassuto, Ophélie; Lenain, Pascal; Contentin, Nathalie; et al.